Study number 780140
Screening Appointments Available.
Dates
Mar 25 2026-Aug 13 2026
Location
Daytona Beach, Florida
Age
18-75
Gender
Male OR Female
Smoker
Yes
Compensation
$21,260
Group
Part B Cohort 1
Study Details
The investigational drug in this research study is being developed for the potential treatment of various autoimmune disorders, which are conditions where the immune system does not work properly.
Daytona Beach, FL is currently recruiting Healthy Males and Females of Non-Childbearing Potential, ages 18-75.
Refer a friend & receive $400 per qualified referral
Women Eligibility Criteria
- Women must be non-childbearing potential
- Permanently sterile at least 6 weeks prior to screening:
- hysterectomy
- bilateral oophorectomy
- bilateral salpingectomy
- Postmenopausal
- Permanently sterile at least 6 weeks prior to screening:
Body Mass Index
- Participants must have a BMI of:
- 18-32
Smoking criteria
- Smoking is not allowed.
Screening procedures
- Screening procedures for this study may include:
- Vitals
- Physical examination
- Electrocardiogram (ECG)
- Collection of blood samples
- Drug and Alcohol testing
- Chest X-ray
Additional Details
Call Now to Schedule Your Screening Appointment!
Part B Cohort 1:
Check-in: Mar 25
Check-out: Apr 1
Follow up Visits: Apr 3
Check-in: Apr 8
Check-out: Apr 16
Check-in: Apr 22
Check-out: Apr 29
Follow up Visits: May 7, 21, Jun 4, 18, Jul 2, 16, 30, Aug 13